# NewVale Capital

NewVale Capital is a Private Equity based in Boulder, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Boulder, United States
- **Region:** North America
- **Address:** 1827 Pearl Street, Boulder, CO 80302, United States
- **Founded:** 2021
- **Assets under management:** Undisclosed
- **Website:** newvalecapital.com
- **LinkedIn:** https://www.linkedin.com/company/newvalecapital

## Regulatory record

- **CRD number:** 328660
- **SEC file number:** 802-130072
- **Registration status:** Registered
- **Reports private funds:** Yes
- **IAPD record:** https://adviserinfo.sec.gov/firm/summary/328660

## About

NewVale Capital invests in the services architecture behind life sciences. The firm is a sector specialist focused on life science services and enabling technologies across drug discovery, clinical research, manufacturing and supply chain, and commercialization. It emphasizes execution-led growth, disciplined operating scale, and a powerful industry network.

## Sectors

- Pharma Services
- Life Sciences
- Enterprise Software
- AI/ML
- Manufacturing & Supply Chain

## Offices

- New York, NY, United States

## People

- Todd Holmes — Managing Partner
- Patrick Lee — Executive Partner
- Rich Fante — Executive Partner
- Sami Hawwa — Principal
- Melanie Larkins — Principal
- Abigail Pohl Pierce — Vice President
- Matt Galle — Associate
- Andra Stene — Vice President, Finance and Operations
- Scott Waldman — Operating Partner
- Anne Whitaker — Operating Partner
- Todd Smith — Operating Partner

## Questions

### Who runs investment decisions at NewVale Capital?

Managing Partner Todd Holmes, a co-founder, leads the investment team from the firm's Boulder headquarters. He is supported by Executive Partners Patrick Lee and Rich Fante, both of whom bring direct life sciences operating and investing experience. Day-to-day deal execution sits with Principals Sami Hawwa and Melanie Larkins.

### What investment stages does NewVale Capital target?

NewVale explicitly invests in the gap between commercial proof points and commercial scale — companies that are revenue-generating, have validated their product with customers, but need growth capital to build out operational infrastructure. This puts the firm between traditional venture capital (which favors earlier, unproven technology risk) and traditional private equity (which often requires greater scale and stable cash flows for leverage).

### Which sectors does NewVale explicitly focus on?

The firm invests exclusively in the services architecture of the life sciences industry, broken into four segments: drug discovery (lab and research services), clinical research (trial execution and data platforms), manufacturing and supply chain (CDMOs and quality systems), and commercialization (launch support and market access). It avoids therapeutics developers and pure biotech platform companies.

### How is NewVale Capital different from a generalist healthcare private equity fund?

NewVale runs a sector-specialist fund size with a narrow mandate limited to outsourced pharma services. The managing partner and executive partners have direct operating experience as former customers of the types of businesses they invest in, creating a sourcing and diligence advantage that a generalist fund covering medical devices, payors, and providers cannot replicate.

### What is NewVale's known posture on co-investments alongside external GPs?

NewVale has demonstrated a willingness to co-invest alongside other specialist growth equity investors, as seen in the Argonaut deal with Telegraph Hill Partners. The firm can structure transactions either as a lead investor or as a syndicate partner, offering flexibility to management teams and other sponsors.

## Related profiles

- [Newtype Ventures](https://altss.com/profile/newtype-ventures)
- [New Value Capital](https://altss.com/profile/new-value-capital)

---

Last updated: 2026-08-11T15:07:34.613Z

Canonical page: https://altss.com/profile/newvale-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology